HARROW, INC. (HROW) Insider Trading
Sector: Pharmaceuticals · Market Cap: $1.6B · 0 insider purchases in the last 7 days
No open market insider purchases at HARROW, INC. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track HROW on your watchlist.
Start for FreeAbout HARROW, INC. Insider Trading
4 insiders at HARROW, INC. (HROW) have purchased stock in the past 90 days, totaling $469K across 4 transactions (15,500 shares).
The most recent purchase was by Director Graves Adrienne L on May 18, 2026 — a $31K buy of 1,000 shares at $31.07, bringing his total holdings to 1,000 shares.
Insiders who purchased: BAUM MARK L (CEO, 1 buy totaling $302K); BOLL ANDREW R. (CFO, 1 buy totaling $105K); Graves Adrienne L (Director, 1 buy totaling $31K); SILVERNAIL LAUREN P (Director, 1 buy totaling $31K).
This insider buying is notable given that HROW had no recorded open market purchases in the nine months before that.
HROW is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $1.6B.
With 4 different insiders buying in the same 90-day window, this qualifies as cluster buying at HROW — a pattern that research suggests can signal conviction among management.
Track HROW insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.